Case
====

One year after kidney transplantation, a 70-year-old man returned to haemodialysis. Induction had consisted in basiliximab, mycophenolate, prednisone and cyclosporine, the latter was switched to tacrolimus after 9 months. Because of rejection under reduced immunosuppression, the graft was removed 6 months after returning to haemodialysis and immunosuppression was completely stopped.

Twelve months later, a large skin tumour grew close to the arteriovenous fistula within 4 weeks ([Figure 1](#fig1){ref-type="fig"}). A surgical excision was undertaken. Macroscopy showed a spindled skin specimen with a centrally located dome-shaped nodule. On histological examination, the tumour presented with crateriform architecture and centrally located papillary proliferation within a keratin plug consistent with the diagnosis of a keratoacanthoma ([Figures 2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}). Keratoacanthomas are benign skin tumors developing from epidermal and hair follicle keratinocytes. Even after histological examination, keratoacanthomas are hard to distinguish from squamous cell carcinoma \[[@bib1]\], the most frequent skin cancer after transplantation \[[@bib2]\]. Additionally, both tumours have similar risk factors such as ultraviolet light and human papillomavirus infection \[[@bib3]\].

![1.6 × 1.5 × 0.5 cm measuring keratoacanthoma close to the arteriovenous fistula used for dialysis access.](ndtplussfr049f01_3c){#fig1}

![Margin of a keratin-filled crater with papillary proliferation of the squamous epithelium.](ndtplussfr049f02_3c){#fig2}

![Mild cellular atypia, on the right side an intraepithelial micro-abscess.](ndtplussfr049f03_3c){#fig3}

Hence, after returning to chronic haemodialysis, a regular dermatological examination is mandatory for previously transplanted patients.
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